Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.
-
Industrie
-
Hospitals and Health Care
-
Größe des Unternehmens
-
201-500 Mitarbeiter
-
Hauptsitz
-
New York, New York
-
Typ
-
Öffentliches Unternehmen
-
Gegründet
-
2008
-
Spezialitäten
-
healthcare, medical, financing, fertility, egg freezing, embryo assessment, pregnancy support, preconception, postpartum, menopause care, return to work support, womens health, and reproductive health